Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease

被引:208
|
作者
Bingham, C
Bulman, MP
Ellard, S
Allen, LIS
Lipkin, GW
van't Hoff, WG
Woolf, AS
Rizzoni, G
Novelli, G
Nicholls, AJ
Hattersley, AT
机构
[1] Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Vasc Med & Diabet Res, Exeter, Devon, England
[2] Queen Elizabeth Hosp, Dept Nephrol, Birmingham, W Midlands, England
[3] UCL, Inst Child Hlth, NephroUrol Unit, London WC1E 6BT, England
[4] Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol & Dialysis, Rome, Italy
[5] Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Sez Genet, Rome, Italy
关键词
D O I
10.1086/316945
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Familial glomerulocystic kidney disease (GCKD) is a dominantly inherited condition characterized by glomerular cysts and variable renal size and function; the molecular genetic etiology is unknown. Mutations in the gene encoding hepatocyte nuclear factor (HNF)-1 beta have been associated with early-onset diabetes and nondiabetic renal disease-particularly renal cystic disease. We investigated a possible role for the HNF-1 beta gene in four unrelated GCKD families and identified mutations in two families: a nonsense mutation in exon 1 (E101X) and a frameshift mutation in exon 2 (P159fsdelT). The family members with HNF-1 beta gene mutations had hypoplastic GCKD and early-onset diabetes or impaired glucose tolerance. We conclude that there is genetic heterogeneity in familial GCKD and that the hypoplastic subtype is a part of the clinical spectrum of the renal cysts and diabetes syndrome that is associated with HNF-1 beta mutations.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 50 条
  • [21] Mutations in the hepatocyte nuclear factor-1α gene in Chinese MODY families: prevalence and functional analysis
    J. Xu
    V. Chan
    W. Zhang
    N. Wat
    K. Lam
    Diabetologia, 2002, 45 : 744 - 746
  • [22] Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations:: evidence for pharmacogenetics in diabetes
    Pearson, ER
    Liddell, WG
    Shepherd, M
    Corrall, RJ
    Hattersley, AT
    DIABETIC MEDICINE, 2000, 17 (07) : 543 - 545
  • [23] Mutations in the hepatocyte nuclear factor-1α gene in Chinese MODY families:: prevalence and functional analysis
    Xu, JY
    Chan, V
    Zhang, WY
    Wat, NMS
    Lam, KSL
    DIABETOLOGIA, 2002, 45 (05) : 744 - 746
  • [24] Characterization of naturally occurring hepatocyte nuclear factor-1α (HNF-1α) gene mutations.
    Cervin, C
    Cilio, C
    Orho-Melander, M
    Ridderstråle, M
    Lehto, M
    Groop, L
    DIABETOLOGIA, 2001, 44 : A65 - A65
  • [25] Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Korean subjects with MODY and familial type 2 diabetes mellitus
    Ahn, KJ
    Kim, BJ
    Kim, SY
    Jung, SY
    Lee, YS
    DIABETES, 2002, 51 : A549 - A549
  • [26] Mutations in hepatocyte nuclear factor-1α in Caucasians originally classified as IDDM
    Ambye, L
    Moller, AM
    Pociot, F
    Nerup, J
    Hansen, T
    Pedersen, O
    DIABETOLOGIA, 1998, 41 : A78 - A78
  • [27] Phenotypic heterogeneity in Chinese patients with hepatocyte nuclear factor-1β mutations
    Wang, Congrong
    Zhang, Rong
    Lu, Jingyi
    Jiang, Feng
    Hu, Cheng
    Zhou, Jian
    Liu, Fang
    Zhang, Feng
    Qin, Wen
    Li, Mei
    Ma, Xiaojing
    Yan, Jingbin
    Bao, Yuqian
    Xiang, Kunsan
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (01) : 119 - 124
  • [28] Linkage analysis excludes familial hypoplastic glomerulocystic kidney disease from chromosome 4 and 16
    Mesoraca, A
    Massari, A
    Novelli, G
    Dallapiccola, B
    Rizzoni, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0462 - A0462
  • [29] Mutations in the hepatocyte nuclear factor-1αgene in diabetic patients initially classified as having type 1 idiopathic
    Kawasaki, E
    Sera, Y
    Abe, T
    Ozaki, M
    Yamakawa, K
    Uotani, S
    Takino, H
    Yamasaki, H
    Yamaguchi, Y
    Matsuura, N
    Eguchi, K
    DIABETES, 1999, 48 : A161 - A161
  • [30] Impaired maximum microvascular hyperaemia in patients with MODY 3 (hepatocyte nuclear factor-1α gene mutations)
    Lee, BC
    Appleton, M
    Shore, AC
    Tooke, JE
    Hattersley, AT
    DIABETIC MEDICINE, 1999, 16 (09) : 731 - 735